KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $2.5 billion.

  • AbbVie's Non-Current Deferred Tax Liability fell 978.54% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year decrease of 978.54%. This contributed to the annual value of $2.6 billion for FY2024, which is 286.25% down from last year.
  • AbbVie's Non-Current Deferred Tax Liability amounted to $2.5 billion in Q3 2025, which was down 978.54% from $2.6 billion recorded in Q2 2025.
  • AbbVie's Non-Current Deferred Tax Liability's 5-year high stood at $5.9 billion during Q4 2021, with a 5-year trough of $2.0 billion in Q3 2022.
  • In the last 5 years, AbbVie's Non-Current Deferred Tax Liability had a median value of $2.7 billion in 2023 and averaged $2.9 billion.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first surged by 29290.93% in 2021, then plummeted by 4525.26% in 2022.
  • Quarter analysis of 5 years shows AbbVie's Non-Current Deferred Tax Liability stood at $5.9 billion in 2021, then decreased by 20.61% to $4.7 billion in 2022, then tumbled by 43.53% to $2.7 billion in 2023, then dropped by 2.86% to $2.6 billion in 2024, then dropped by 3.84% to $2.5 billion in 2025.
  • Its last three reported values are $2.5 billion in Q3 2025, $2.6 billion for Q2 2025, and $2.6 billion during Q1 2025.